Skip to main content
OpenTrials
Completed

NCT Number: NCT07179965

Nutrition, Meal Regularity and Quality of Life in Inflammatory Bowel Disease

Aims: This study aimed to assess nutritional status, dietary habits, meal patterns, gastrointestinal symptoms, quality of life, and depression in Inflammatory Bowel Disease (IBD) patients.

Methods: Data were collected at a university hospital using the 24-Hour Dietary Recall, IBD Quality of Life Questionnaire, Beck Depression Inventory II, and the Gastrointestinal Symptom Rating Scale.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammatory Bowel Disease (IBD) Behavior Behavior, Animal Diet Habits Digestive System Diseases Feeding Behavior Gastroenteritis Gastrointestinal Gastrointestinal Diseases Inflammation Inflammatory Bowel Diseases Intestinal Diseases Nutrition Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Istanbul University Cerrahpaşa

Istanbul, Turkey (Türkiye)

About this study

Inflammatory Bowel Disease (IBD), which is divided into Ulcerative Colitis and Crohn's Disease, is influenced by various environmental factors, including nutrition, and significantly reduces the quality of life. This study included 50 individuals aged 18-75 who were diagnosed with Inflammatory Bowel Disease by a physician, had no communication difficulties, and were able to make their own food choices. The study aimed to evaluate the nutritional status, dietary habits, food consumption frequencies, and meal patterns of the patients and, based on these data, to determine their gastrointestinal symptoms, quality of life, and depression status. The study commenced with ethical approval and was conducted with patients at the Gastroenterology Clinic of Istanbul University Cerrahpaşa Medical Faculty Hospital between August 2023 and September 2023. The research is cross-sectional. Data were collected using the General Information and Nutrition Behaviors Questionnaire, Food Frequency Questionnaire, 24-Hour Dietary Recall, Inflammatory Bowel Disease Quality of Life Questionnaire, Beck Depression Inventory, and Gastrointestinal Symptom Rating Scale.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Inclusion criteria required the ability to communicate effectively and make independent dietary choices.

Exclusion criteria

  • Individuals with psychiatric disorders, or those who were pregnant or breastfeeding, were excluded.

Treatment and study plan

observation

Other

IBD patients

Primary outcomes

  1. Weight

    Time frame: Baseline

    kg

  2. Height

    Time frame: Baseline

    cm

  3. 24-Hour Dietary Recall

    Time frame: 24-Hour Dietary Recall

  4. IBD Quality of Life Questionnaire

    Time frame: Baseline

    To assess quality of life, the "Inflammatory Bowel Disease Quality of Life Questionnaire," consisting of 36 items and evaluating systemic symptoms, bowel symptoms, functional impairment, social impairment, and emotional functioning, was used. A higher score is associated with better quality of life.

  5. Beck Depression Inventory II

    Time frame: Baseline

    The Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire assessing characteristic attitudes and symptoms of depression, was administered at baseline (single time point, at questionnaire administration). Each item is scored on a 4-point scale (0-3), with a total score range of 0-63. Higher scores indicate greater severity of depression, classified as minimal (0-13), mild (14-19), moderate (20-28), and severe (29-63).

  6. Gastrointestinal Symptom Rating Scale

    Time frame: Baseline

    The Gastrointestinal Symptom Rating Scale (GSRS), a 15-item questionnaire comprising five subcategories (abdominal pain, indigestion, diarrhea, constipation, and reflux), was administered at baseline (single time point, at questionnaire administration). Each item is scored on a 7-point Likert scale (1-7), yielding a total score range of 15-105, with higher scores indicating more severe gastrointestinal symptoms.

Sponsors and collaborators

Lead sponsor

Istinye University

Other

Collaborators

  • Istanbul University - Cerrahpasa

Registry information

Acronym: Public health

Important dates

Study start
2023
Primary completion
2023
Study completion
2025
First posted
Sep 18, 2025
Registry last updated
Sep 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.